|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Rosalind Franklin University of Medicine and Science |
|---|---|
| Collaborators: |
Insulin Dependent Diabetes Trust American Pain Society |
| Information provided by: | Rosalind Franklin University of Medicine and Science |
| ClinicalTrials.gov Identifier: | NCT00858351 |
Purpose
The purpose of this study is to examine potential treatment options for a condition in diabetics that causes tingling, pain, and numbness in the hands and /or feet, also known as diabetic peripheral neuropathy.
| Condition | Intervention |
|---|---|
|
Diabetic Neuropathy, Painful |
Behavioral: Thermal Biofeedback Assisted Relaxation Behavioral: Discussion with therapist |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | A Placebo-Controlled Trial of Thermal Biofeedback Assisted Relaxation for the Treatment of Diabetic Neuropathy: An Evaluation of Outcomes and Mechanisms |
| Estimated Enrollment: | 60 |
| Study Start Date: | November 2007 |
| Estimated Study Completion Date: | February 2010 |
| Estimated Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Thermal Biofeedback Assisted Relaxation |
Behavioral: Thermal Biofeedback Assisted Relaxation
6 sessions, 25 minutes in duration of relaxation and imagery training while temperature of hands and feet are recorded.
|
| Active Comparator: Discussion |
Behavioral: Discussion with therapist
6 sessions, 25 minutes each, discussing topics with a therapist.
|
Participants attend 6 sessions lasting from 35 minutes to 2 hours (depending on the session). Sessions can be scheduled once or twice per week. Sessions involve a walking task, filling out questionnaires, and having temperature of hands and feet monitored. This study involves no drugs, blood draws, or any other invasive procedures. Participants are urged to continue the treatment of diabetes and diabetic neuropathy as directed by their physician for the duration of their involvement with the study. After 3 months, a packet of questionnaires will be mailed with a stamped addressed envelope to be returned.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | Kenneth Kessler, Ph.D., Associate Professor, Rosalind Franklin Univeristy of Medicine and Science |
| ClinicalTrials.gov Identifier: | NCT00858351 History of Changes |
| Other Study ID Numbers: | 200.97PY |
| Study First Received: | March 6, 2009 |
| Last Updated: | January 5, 2011 |
| Health Authority: | United States: Institutional Review Board |
|
Diabetes Neuropathy Peripheral Painful Thermal |
Temperature Biofeedback Relaxation Diabetic |
|
Diabetic Neuropathies Pain Demyelinating Diseases Polyneuropathies Nerve Compression Syndromes Neurologic Manifestations Neurotoxicity Syndromes Peripheral Nervous System Diseases |
Neuromuscular Diseases Nervous System Diseases Diabetes Complications Diabetes Mellitus Endocrine System Diseases Signs and Symptoms Poisoning Substance-Related Disorders |